Consortium Building
Lead Research Organisation:
Newcastle University
Department Name: Institute of Cellular Medicine
Abstract
Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.
People |
ORCID iD |
| David Jones (Principal Investigator) |
Publications
Afford SC
(2014)
Vascular cell adhesion molecule 1 expression by biliary epithelium promotes persistence of inflammation by inhibiting effector T-cell apoptosis.
in Hepatology (Baltimore, Md.)
Brain JG
(2013)
Biliary epithelial senescence and plasticity in acute cellular rejection.
in American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Carbone M
(2013)
Sex and age are determinants of the clinical phenotype of primary biliary cirrhosis and response to ursodeoxycholic acid.
in Gastroenterology
Carbone M
(2014)
Risk stratification in primary biliary cirrhosis using the UK-PBC Research Cohort
in Hepatology
Carbone M
(2013)
The effect of liver transplantation on fatigue in patients with primary biliary cirrhosis: a prospective study.
in Journal of hepatology
Dyson J
(2014)
Diagnosis and management of patients with primary biliary cirrhosis.
in Clinical liver disease
Dyson JK
(2015)
Novel therapeutic targets in primary biliary cirrhosis.
in Nature reviews. Gastroenterology & hepatology
Dyson JK
(2015)
Unmet clinical need in autoimmune liver diseases.
in Journal of hepatology
Frith J
(2014)
Orthostatic intolerance is common in chronic disease--a clinical cohort study.
in International journal of cardiology
| Description | Clinical Research Training Fellowship |
| Amount | £262,000 (GBP) |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 08/2014 |
| End | 07/2017 |
| Description | Cohort Development |
| Amount | £50,000 (GBP) |
| Organisation | Intercept Pharmaceuticals |
| Sector | Private |
| Country | United States |
| Start | 01/2012 |
| End | 12/2013 |
| Description | Data Input support |
| Amount | £27,820 (GBP) |
| Organisation | Lumena Pharmaceuticals |
| Sector | Private |
| Country | United States |
| Start | 11/2013 |
| End | 12/2017 |
| Description | HPRU: Toxicology of Chronic Disease |
| Amount | £500,000 (GBP) |
| Organisation | National Institute for Health Research |
| Sector | Public |
| Country | United Kingdom |
| Start | 04/2014 |
| End | 03/2019 |
| Description | Meeting Organisation |
| Amount | £60,000 (GBP) |
| Organisation | Intercept Pharmaceuticals |
| Sector | Private |
| Country | United States |
| Start | 12/2013 |
| End | 06/2014 |
| Description | OCA on cognitive Symptoms |
| Amount | £22,169 (GBP) |
| Organisation | Intercept Pharmaceuticals |
| Sector | Private |
| Country | United States |
| Start | 12/2014 |
| End | 11/2017 |
| Description | Sheila Sherlock Fellowship |
| Amount | € 30,000 (EUR) |
| Organisation | European Association for the Study of the Liver (EASL) |
| Sector | Charity/Non Profit |
| Country | Switzerland |
| Start | 05/2014 |
| End | 04/2015 |
| Description | Stratified Medicine |
| Amount | £4,972,138 (GBP) |
| Funding ID | MR/L001489/1 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 12/2013 |
| End | 11/2017 |
| Description | TRC Doctoral and Postdoctoral Fellowships (G Mells and J Dyson) |
| Amount | £560,000 (GBP) |
| Organisation | National Institute for Health Research |
| Sector | Public |
| Country | United Kingdom |
| Start | 08/2014 |
| End | 07/2018 |
| Description | Wellcome Trust Senior Research Fellowship (H Cordell) |
| Amount | £1,052,135 (GBP) |
| Funding ID | 102858/Z/13/Z |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 10/2014 |
| End | 09/2019 |
| Description | Trustee of the the PBC Foundation |
| Organisation | PBC Foundation |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Unique and long-lasting partnership with a patient group. This brings a unique perspective to our research. During the COVID pandemic we have worked together on a patient education programme, including open Q & A fora which have had over 25,000 participants |
| Collaborator Contribution | See above |
| Impact | Multiple papers and grants |
| Description | Leading Edge - School workshops |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Schools |
| Results and Impact | The day gave students an increased understanding of liver disease and information about a career in academia Students visited the Fibrosis lab at Newcastle University |
| Year(s) Of Engagement Activity | 2010,2011,2012,2014 |
| URL | http://research.ncl.ac.uk/fibrosislab/newsevents/publicengagement/leadingedge/ |
| Description | Science on a plate - Local School Engagement |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Schools |
| Results and Impact | The workshops gave students a better understanding of liver disease physiology unknown |
| Year(s) Of Engagement Activity | 2014 |
| URL | http://research.ncl.ac.uk/fibrosislab/newsevents/publicengagement/scienceonaplatesoap/ |